Resonac Holdings Corporation (TOKYO: 4004) announces the revision of its forecast of consolidated business results for the full year ending on December 31, 2023, which was announced on Aug. 8, 2023.

Reasons for the revision of forecast

Net sales are expected to increase mainly in the Semiconductor and Electronic Materials segment and the Chemicals segment, and the full-year forecast is revised upward.

Operating income is revised upward due to the upward revision of the net sales forecast and the reduction of common expenses throughout the company. Ordinary income is revised upward due to the upward revision of operating income. Net income attributable to owners of the parent is revised downward. In the third quarter (Jul - Sep), an extraordinary income of 24.3 billion yen was recorded for the transfer of the diagnostic medicine business, but we expect to record an extraordinary loss on structural reforms related to the restructuring of the hard disk media business. Structural reform-related expenses include extra retirement payments of 6.5 billion yen and an impairment loss of 4.1 billion yen.

Performance forecast and other statements pertaining to the future as contained in this presentation are based on the information available as of today and assumptions as of today regarding risk factors that could affect our future performance. Actual results may differ materially from the forecast due to a variety of risk factors, including, but not limited to, the international situation, costs of naphtha and other raw materials, demand or market conditions for our products such as graphite electrodes and other commodities and foreign exchange rates. We undertake no obligation to update the forward-looking statements unless required by law.

Contact:

Tel: 81-3-6263-8003

(C) 2023 Electronic News Publishing, source ENP Newswire